Evidence from leading journals since 2021 consistently documents both pronounced vaccine inequity between countries and substantial within‑country access gaps, especially for COVID‑19 but also for routine childhood...
In the last days, there have been notable developments in COVID‑19 vaccine formulations, WHO prequalification, and – as reported before – politically driven schedule changes in the US. Very recent product...
Download Infographic Overview Vaccines contain active ingredients (antigens; mRNA) and inactive ingredients such as stabilizers, antimicrobials, inactivating agents, antibiotics, and residues from the production...
WHO’s vaccination work represents one of the clearest examples of sustained, science‑based global cooperation in public health, and the attached summary illustrates how far‑reaching and internally coherent this effort...
WEEK 21 All about vaccines & vaccination ↗ WEEK 22 The future of protein-based vaccines ↗ WEEK 23 Vaccine frontlines: Polio, mRNA breakthroughs & what is next ↗ WEEK 24 Three decades of DTaP: the ongoing story...
Download Infographic Overview Historical background: Combination vaccines have been used since 1945, beginning with the trivalent influenza vaccine. Vaccine composition: They combine either different serotypes of one...
In short: Classic vaccines have picked most of the low-hanging fruit: stable-antigen pathogens tamed by robust neutralizing antibodies, leaving the real fun to TB, HIV and other shape-shifters that demand sophisticated...
Europe On 11 December 2025, EMA’s CHMP recommended granting marketing authorisation in the EU for mNexspike, an mRNA COVID-19 vaccine targeting the LP.8.1 variant for the 2025–26 season, adding another option to the...
There are moments when recognition feels less like an achievement and more like a quiet affirmation – a reminder of why the journey began, and why it continues. For me, health literacy has always been deeply...